Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Stein

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Chemistry & Biology|May 1, 1996
Exploiting the potential of antisense: beyond phosphorothioate oligodeoxynucleotidesC A Stein
Trends in Biotechnology|May 1, 1996
Phosphorothioate antisense oligodeoxynucleotides: questions of specificityC A Stein
Journal of the National Cancer Institute|April 3, 1996
Antitumor effects of antisense phosphorothioate c-myc oligodeoxynucleotides: a question of mechanismC A Stein
Nature Biotechnology|September 12, 2007
The Genasense 'learning curve'C A Stein
Pharmacology & Therapeutics|March 31, 2000
Is irrelevant cleavage the price of antisense efficacy?C A Stein
Nature Biotechnology|August 3, 1999
Hybridization prediction gets to first baseC A Stein
Seminars in Oncology|December 22, 1999
Mechanisms of action of taxanes in prostate cancerC A Stein
Oligonucleotides|October 24, 2007
Genasense: it ain't over till the fat lady singsC A Stein
Cancer Research|May 15, 1993
Suramin: a novel antineoplastic agent with multiple potential mechanisms of actionC A Stein
Leukemia|October 1, 1992
Anti-sense oligodeoxynucleotides--promises and pitfallsC A Stein
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Chemistry & Biology|May 1, 1996
Exploiting the potential of antisense: beyond phosphorothioate oligodeoxynucleotidesC A Stein
Trends in Biotechnology|May 1, 1996
Phosphorothioate antisense oligodeoxynucleotides: questions of specificityC A Stein
Journal of the National Cancer Institute|April 3, 1996
Antitumor effects of antisense phosphorothioate c-myc oligodeoxynucleotides: a question of mechanismC A Stein
Nature Biotechnology|September 12, 2007
The Genasense 'learning curve'C A Stein
Pharmacology & Therapeutics|March 31, 2000
Is irrelevant cleavage the price of antisense efficacy?C A Stein
Nature Biotechnology|August 3, 1999
Hybridization prediction gets to first baseC A Stein
Seminars in Oncology|December 22, 1999
Mechanisms of action of taxanes in prostate cancerC A Stein
Oligonucleotides|October 24, 2007
Genasense: it ain't over till the fat lady singsC A Stein
Cancer Research|May 15, 1993
Suramin: a novel antineoplastic agent with multiple potential mechanisms of actionC A Stein
Leukemia|October 1, 1992
Anti-sense oligodeoxynucleotides--promises and pitfallsC A Stein
Pageof 16